“An Open-Label Study Evaluating the Long-Term Efficacy, Quality of Life, and Safety of Lidose-Isotretinoin (ABSORICA) Capsules Administered Without Food in Patients with Severe Recalcitrant Nodular Acne: Interim Analysis of 20-Week Active Treatment Period”, J of Skin, vol. 2, no. S1, p. S33, Feb. 2018, doi: 10.25251/skin.2.supp.32.